Production (Stage)
PharmaRoth Labs, Inc.
ROTH
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2,412.71% | 1,530.00% | 1,406.54% | 50.38% | 54.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3,074.03% | 1,530.00% | 1,406.54% | 50.38% | 54.70% |
| Operating Income | -1,967.96% | -1,530.00% | -1,406.54% | -50.38% | -54.70% |
| Income Before Tax | -3,395.58% | -3,034.71% | -3,040.52% | -1,958.78% | -54.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3,395.58% | -3,034.71% | -3,040.52% | -1,958.78% | -54.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,395.58% | -3,034.71% | -3,040.52% | -1,958.78% | -54.70% |
| EBIT | -1,967.96% | -1,530.00% | -1,406.54% | -50.38% | -54.70% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -4,700.00% | -4,000.00% | -3,600.00% | -2,000.00% | 0.00% |
| Normalized Basic EPS | -1,800.00% | -1,300.00% | -1,000.00% | 0.00% | 0.00% |
| EPS Diluted | -4,700.00% | -4,000.00% | -3,600.00% | -2,000.00% | 0.00% |
| Normalized Diluted EPS | -1,800.00% | -1,300.00% | -1,000.00% | 0.00% | 0.00% |
| Average Basic Shares Outstanding | 2.10% | 0.09% | 0.09% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 2.10% | 0.09% | 0.09% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |